Personalized Cancer Medicine
Personalized Cancer Medicine market is segmented by region (country), players, by Type and by App ... Read More
Global and United States Risedronate Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Risedronate Product Introduction
1.2 Global Risedronate Outlook 2017 VS 2022 VS 2028
1.2.1 Global Risedronate Sales in US$ Million for the Year 2017-2028
1.2.2 Global Risedronate Sales in Volume for the Year 2017-2028
1.3 United States Risedronate Outlook 2017 VS 2022 VS 2028
1.3.1 United States Risedronate Sales in US$ Million for the Year 2017-2028
1.3.2 United States Risedronate Sales in Volume for the Year 2017-2028
1.4 Risedronate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Risedronate in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Risedronate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Risedronate Market Dynamics
1.5.1 Risedronate Industry Trends
1.5.2 Risedronate Market Drivers
1.5.3 Risedronate Market Challenges
1.5.4 Risedronate Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Risedronate Market Segment by Type
2.1.1 5 mg Tablets
2.1.2 35 mg Tablets
2.1.3 75 mg Tablets
2.1.4 150 mg Tablets
2.2 Global Risedronate Market Size by Type
2.2.1 Global Risedronate Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Risedronate Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Risedronate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Risedronate Market Size by Type
2.3.1 United States Risedronate Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Risedronate Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Risedronate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Risedronate Market Segment by Application
3.1.1 Postmenopausal Osteoporosis
3.1.2 Men with Osteoporosis
3.2 Global Risedronate Market Size by Application
3.2.1 Global Risedronate Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Risedronate Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Risedronate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Risedronate Market Size by Application
3.3.1 United States Risedronate Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Risedronate Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Risedronate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Risedronate Competitor Landscape by Company
4.1 Global Risedronate Market Size by Company
4.1.1 Top Global Risedronate Manufacturers Ranked by Revenue (2021)
4.1.2 Global Risedronate Revenue by Manufacturer (2017-2022)
4.1.3 Global Risedronate Sales by Manufacturer (2017-2022)
4.1.4 Global Risedronate Price by Manufacturer (2017-2022)
4.2 Global Risedronate Concentration Ratio (CR)
4.2.1 Risedronate Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Risedronate in 2021
4.2.3 Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Risedronate Manufacturing Base Distribution, Product Type
4.3.1 Global Risedronate Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Risedronate Product Type
4.3.3 Date of International Manufacturers Enter into Risedronate Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Risedronate Market Size by Company
4.5.1 Top Risedronate Players in United States, Ranked by Revenue (2021)
4.5.2 United States Risedronate Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Risedronate Sales by Players (2020, 2021 & 2022)
5 Global Risedronate Market Size by Region
5.1 Global Risedronate Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Risedronate Market Size in Volume by Region (2017-2028)
5.2.1 Global Risedronate Sales in Volume by Region: 2017-2022
5.2.2 Global Risedronate Sales in Volume Forecast by Region (2023-2028)
5.3 Global Risedronate Market Size in Value by Region (2017-2028)
5.3.1 Global Risedronate Sales in Value by Region: 2017-2022
5.3.2 Global Risedronate Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Risedronate Market Size YoY Growth 2017-2028
6.1.2 North America Risedronate Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Risedronate Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Risedronate Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Risedronate Market Size YoY Growth 2017-2028
6.3.2 Europe Risedronate Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Risedronate Market Size YoY Growth 2017-2028
6.4.2 Latin America Risedronate Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Risedronate Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Risedronate Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck
7.1.1 Merck Corporation Information
7.1.2 Merck Description and Business Overview
7.1.3 Merck Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck Risedronate Products Offered
7.1.5 Merck Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Risedronate Products Offered
7.2.5 Amgen Recent Development
7.3 Teva
7.3.1 Teva Corporation Information
7.3.2 Teva Description and Business Overview
7.3.3 Teva Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Teva Risedronate Products Offered
7.3.5 Teva Recent Development
7.4 Mylan
7.4.1 Mylan Corporation Information
7.4.2 Mylan Description and Business Overview
7.4.3 Mylan Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Mylan Risedronate Products Offered
7.4.5 Mylan Recent Development
7.5 Apotex
7.5.1 Apotex Corporation Information
7.5.2 Apotex Description and Business Overview
7.5.3 Apotex Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Apotex Risedronate Products Offered
7.5.5 Apotex Recent Development
7.6 Sanofi
7.6.1 Sanofi Corporation Information
7.6.2 Sanofi Description and Business Overview
7.6.3 Sanofi Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi Risedronate Products Offered
7.6.5 Sanofi Recent Development
7.7 Abbott
7.7.1 Abbott Corporation Information
7.7.2 Abbott Description and Business Overview
7.7.3 Abbott Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Abbott Risedronate Products Offered
7.7.5 Abbott Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Risedronate Products Offered
7.8.5 Novartis Recent Development
7.9 Tecoland
7.9.1 Tecoland Corporation Information
7.9.2 Tecoland Description and Business Overview
7.9.3 Tecoland Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Tecoland Risedronate Products Offered
7.9.5 Tecoland Recent Development
7.10 Taj Pharmaceuticals
7.10.1 Taj Pharmaceuticals Corporation Information
7.10.2 Taj Pharmaceuticals Description and Business Overview
7.10.3 Taj Pharmaceuticals Risedronate Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Taj Pharmaceuticals Risedronate Products Offered
7.10.5 Taj Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Risedronate Industry Chain Analysis
8.2 Risedronate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Risedronate Distributors
8.3 Risedronate Production Mode & Process
8.4 Risedronate Sales and Marketing
8.4.1 Risedronate Sales Channels
8.4.2 Risedronate Distributors
8.5 Risedronate Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Risedronate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Risedronate Market Trends
Table 3. Risedronate Market Drivers
Table 4. Risedronate Market Challenges
Table 5. Risedronate Market Restraints
Table 6. Global Risedronate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Risedronate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Risedronate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Risedronate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Risedronate Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Risedronate Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Risedronate Revenue Share by Manufacturer, 2017-2022
Table 13. Global Risedronate Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Risedronate Sales Share by Manufacturer, 2017-2022
Table 15. Global Risedronate Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Risedronate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Risedronate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risedronate as of 2021)
Table 18. Top Players of Risedronate in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Risedronate Product Type
Table 20. Date of International Manufacturers Enter into Risedronate Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Risedronate Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Risedronate Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Risedronate Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Risedronate Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Risedronate Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Risedronate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Risedronate Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Risedronate Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Risedronate Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Risedronate Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Risedronate Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Risedronate Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Risedronate Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Risedronate Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Risedronate Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Risedronate Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Risedronate Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Risedronate Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Risedronate Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Risedronate Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Merck Risedronate Product
Table 46. Merck Recent Development
Table 47. Amgen Corporation Information
Table 48. Amgen Description and Business Overview
Table 49. Amgen Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Amgen Product
Table 51. Amgen Recent Development
Table 52. Teva Corporation Information
Table 53. Teva Description and Business Overview
Table 54. Teva Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. Teva Product
Table 56. Teva Recent Development
Table 57. Mylan Corporation Information
Table 58. Mylan Description and Business Overview
Table 59. Mylan Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Mylan Product
Table 61. Mylan Recent Development
Table 62. Apotex Corporation Information
Table 63. Apotex Description and Business Overview
Table 64. Apotex Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. Apotex Product
Table 66. Apotex Recent Development
Table 67. Sanofi Corporation Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 70. Sanofi Product
Table 71. Sanofi Recent Development
Table 72. Abbott Corporation Information
Table 73. Abbott Description and Business Overview
Table 74. Abbott Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 75. Abbott Product
Table 76. Abbott Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Tecoland Corporation Information
Table 83. Tecoland Description and Business Overview
Table 84. Tecoland Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 85. Tecoland Product
Table 86. Tecoland Recent Development
Table 87. Taj Pharmaceuticals Corporation Information
Table 88. Taj Pharmaceuticals Description and Business Overview
Table 89. Taj Pharmaceuticals Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 90. Taj Pharmaceuticals Product
Table 91. Taj Pharmaceuticals Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Risedronate Customers List
Table 95. Risedronate Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Risedronate Product Picture
Figure 2. Global Risedronate Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Risedronate Market Size 2017-2028 (US$ Million)
Figure 4. Global Risedronate Sales 2017-2028 (MT)
Figure 5. United States Risedronate Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Risedronate Market Size 2017-2028 (US$ Million)
Figure 7. United States Risedronate Sales 2017-2028 (MT)
Figure 8. United States Risedronate Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Risedronate Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Risedronate Report Years Considered
Figure 11. Product Picture of 5 mg Tablets
Figure 12. Product Picture of 35 mg Tablets
Figure 13. Product Picture of 75 mg Tablets
Figure 14. Product Picture of 150 mg Tablets
Figure 15. Global Risedronate Market Share by Type in 2022 & 2028
Figure 16. Global Risedronate Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Risedronate Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Risedronate Sales by Type (2017-2028) & (MT)
Figure 19. Global Risedronate Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Risedronate Price by Type (2017-2028) & (USD/Kg)
Figure 21. United States Risedronate Market Share by Type in 2022 & 2028
Figure 22. United States Risedronate Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Risedronate Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Risedronate Sales by Type (2017-2028) & (MT)
Figure 25. United States Risedronate Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Risedronate Price by Type (2017-2028) & (USD/Kg)
Figure 27. Product Picture of Postmenopausal Osteoporosis
Figure 28. Product Picture of Men with Osteoporosis
Figure 29. Global Risedronate Market Share by Application in 2022 & 2028
Figure 30. Global Risedronate Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Risedronate Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Risedronate Sales by Application (2017-2028) & (MT)
Figure 33. Global Risedronate Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Risedronate Price by Application (2017-2028) & (USD/Kg)
Figure 35. United States Risedronate Market Share by Application in 2022 & 2028
Figure 36. United States Risedronate Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Risedronate Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Risedronate Sales by Application (2017-2028) & (MT)
Figure 39. United States Risedronate Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Risedronate Price by Application (2017-2028) & (USD/Kg)
Figure 41. North America Risedronate Sales in Volume Growth Rate 2017-2028 (MT)
Figure 42. North America Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Risedronate Sales in Volume Growth Rate 2017-2028 (MT)
Figure 46. Europe Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Risedronate Sales in Volume Growth Rate 2017-2028 (MT)
Figure 53. Asia-Pacific Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Risedronate Sales in Volume Growth Rate 2017-2028 (MT)
Figure 65. Latin America Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Risedronate Sales in Volume Growth Rate 2017-2028 (MT)
Figure 70. Middle East & Africa Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Risedronate Value Chain
Figure 75. Risedronate Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck Amgen Teva Mylan Apotex Sanofi Abbott Novartis Tecoland Taj Pharmaceuticals